APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer's disease

Neural Regeneration Research

Volumn 9, Issue 6, 2014, Pages 653-660

  Zhou, Qin ^a,b   Peng, Dan Tao ^a   Yuan, Xin Rui ^a   Lv, Ze Ping ^b   Pang, Sheng Hang ^b   Jiang, Wen Yu ^b   Yang, Chu Yu ^b   Shi, Xiao Hong ^a   Pang, Guo Fang ^b   Yang, Yi Ge ^a   Xie, Hai Qun ^b   Zhang, Wan Dong ^c   Hu, Cai You ^b   Yang, Ze ^a  

^a BEIJING HOSPITAL   (China)

^b Guangxi Zhuangzu Zizhiqu Jiangbin Yiyuan   (China)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Alzheimer's disease; Apolipoprotein CI; Apolipoprotein E; Cognitive disorders; Dementia; Low density lipoprotein receptor related protein; Nerve degeneration; Neural regeneration; NSFC grant; Polymorphism

Indexed keywords

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN CI GENE; APOLIPOPROTEIN E GENE; ARTICLE; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GEL ELECTROPHORESIS; GENE; GENE FREQUENCY; GENE INTERACTION; GENOTYPE; HUMAN; LONGITUDINAL STUDY; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN GENE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; RATING SCALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCORING SYSTEM; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 84901000781     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.130117     Document Type: Article

References (49)

1. Abildayeva K, Berbee JF, Blokland A, Jansen PJ, Hoek FJ, Meijer O, Lutjohann D, Gautier T, Pillot T, De Vente J, Havekes LM, Ramaekers FC, Kuipers F, Rensen PC, Mulder M (2008) Human apolipoprotein C-I expression in mice impairs learning and memory functions. J Lipid Res 49:856-869.
2. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. Arlington, USA.
3. Bangen KJ, Beiser A, Delano-Wood L, Nation DA, Lamar M, Libon DJ, Bondi MW, Seshadri S, Wolf PA, Au R (2013) APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline. J Stroke Cerebrovasc Dis 22:1361-1369.
4. Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10:819-828.
5. Basak JM, Verghese PB, Yoon H, Kim J, Holtzman DM (2012) Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Abeta uptake and degradation by astrocytes. J Biol Chem 287:13959-13971.
6. Berbée JF, van der Hoogt CC, Kleemann R, Schippers EF, Kitchens RL, van Dissel JT, Bakker-Woudenberg IA, Havekes LM, Rensen PC (2006) Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsis. FASEB J 20:2162-2164.
7. Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D (2007) Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Arch Neurol 64:1306-1311.
8. Caselli RJ, Reiman EM, Osborne D, Hentz JG, Baxter LC, Hernandez JL, Alexander GG (2004) Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology 62:1990-1995.
9. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923.
10. Cruchaga C, Haller G, Chakraverty S, Mayo K, Vallania FL, Mitra RD, Faber K, Williamson J, Bird T, Diaz-Arrastia R, Foroud TM, Boeve BF, Graff-Radford NR, St JP, Lawson M, Ehm MG, Mayeux R, Goate AM (2012) Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families. PLoS One 7:e31039.
11. Cummings JL (1993) Mini-Mental State Examination. Norms, normals, and numbers. JAMA 269:2420-2421.
12. Cuzzo LM, Ross-Cisneros FN, Yee KM, Wang MY, Sadun AA (2011) Low-density lipoprotein receptor-related protein is decreased in optic neuropathy of Alzheimer disease. J Neuroophthalmol 31:139-146.
13. Devan WJ, Falcone GJ, Anderson CD, Jagiella JM, Schmidt H, Hansen BM, Jimenez-Conde J, Giralt-Steinhauer E, Cuadrado-Godia E, Soriano C, Ayres AM, Schwab K, Kassis SB, Valant V, Pera J, Urbanik A, Viswanathan A, Rost NS, Goldstein JN, Freudenberger P, et al. (2013) Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage. Stroke 44:1578-1583.
14. Drzezga A, Grimmer T, Henriksen G, Mühlau M, Perneczky R, Miederer I, Praus C, Sorg C, Wohlschläger A, Riemenschneider M (2009) Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease. Neurology 72:1487-1494.
15. Elias-Sonnenschein LS, Viechtbauer W, Ramakers IH, Verhey FR, Visser PJ (2011) Predictive value of APOE-epsilon4 allele for progression from MCI to AD-type dementia: a meta-analysis. J Neurol Neurosurg Psychiatry 82:1149-1156.
16. Emi M, Wu LL, Robertson MA, Myers RL, Hegele RA, Williams RR, White R, Lalouel JM (1988) Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 3:373-379.
17. Fallin D, Kundtz A, Town T, Gauntlett AC, Duara R, Barker W, Crawford F, Mullan M (1997) No association between the low density lipoprotein receptor-related protein (LRP) gene and late-onset Alzheimer's disease in a community-based sample. Neurosci Lett 233:145-147.
18. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, Russell RW, Symon L (1975) Cerebral blood flow in dementia. Arch Neurol 32:632-637.
19. Hollenbach E, Ackermann S, Hyman BT, Rebeck GW (1998) Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease. Neurology 50:1905-1907.
20. Holtzman DM, Herz J, Bu G (2012) Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med 2:a6312.
21. Hong CJ, Liu TY, Liu HC, Wang SJ, Fuh JL, Chi CW, Lee KY, Sim CB (1996) Epsilon 4 allele of apolipoprotein E increases risk of Alzheimer's disease in a Chinese population. Neurology 46:1749-1751.
22. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566-572.
23. Jin C, Li W, Yuan J, Xu W, Cheng Z (2012) Association of the CR1 polymorphism with ate-onset Alzheimer's disease in Chinese Han populations: a meta-analysis. Neurosci Lett 527:46-49.
24. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, et al. (2013) Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 368:107-116.
25. Kamboh MI, Ferrell RE, DeKosky ST (1998) Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene. Neurosci Lett 244:65-68.
26. Kang DE, Saitoh T, Chen X, Xia Y, Masliah E, Hansen LA, Thomas RG, Thal LJ, Katzman R (1997) Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), and apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 49:56-61.
27. Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer's disease. Neuron 63:287-303.
28. Kok E, Haikonen S, Luoto T, Huhtala H, Goebeler S, Haapasalo H, Karhunen PJ (2009) Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. Ann Neurol 65:650-657.
29. Kolsch H, Ptok U, Mohamed I, Schmitz S, Rao ML, Maier W, Heun R (2003) Association of the C766T polymorphism of the low-density lipoprotein receptor-related protein gene with Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 121:128-130.
30. Kontula K, Aalto-Setala K, Kuusi T, Hamalainen L, Syvanen AC (1990) Apolipoprotein E polymorphism determined by restriction enzyme analysis of DNA amplified by polymerase chain reaction: convenient alternative to phenotyping by isoelectric focusing. Clin Chem 36:2087-2092.
31. Lendon CL, J Talbot C, Craddock NJ, Woo Han S, Wragg M, Morris JC, Goate AM (1997) Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population. Neurosci Lett 222:187-190.
32. Li H, Wetten S, Li L, St JP, Upmanyu R, Surh L, Hosford D, Barnes MR, Briley JD, Borrie M, Coletta N, Delisle R, Dhalla D, Ehm MG, Feldman HH, Fornazzari L, Gauthier S, Goodgame N, Guzman D, Hammond S, et al. (2008) Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol 65:45-53.
33. Liu CC, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9:106-118.
34. Loparev VN, Cartas MA, Monken CE, Velpandi A, Srinivasan A (1991) An efficient and simple method of DNA extraction from whole blood and cell lines to identify infectious agents. J Virol Methods 34:105-112.
35. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944.
36. Meng X, D'Arcy C (2012) Apolipoprotein E gene, environmental risk factors, and their interactions in dementia among seniors. Int J Geriatr Psychiatry 28:1005-1014.
37. Nagata T, Shinagawa S, Kuerban B, Shibata N, Ohnuma T, Arai H, Nakayama K, Yamada H (2013) Age-Related Association between Apolipoprotein E epsilon4 and Cognitive Function in Japanese Patients with Alzheimer's Disease. Dement Geriatr Cogn Dis Extra 3:66-73.
38. Nillesen WM, Smeets HJ, van Oost BA (1990) Human ApoCI HpaI restriction site polymorphism revealed by the polymerase chain reaction. Nucleic Acids Res 18:3428.
39. Nordberg A, Carter SF, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, Perani D, Forsberg A, Langstrom B, Scheinin N, Karrasch M, Nagren K, Grimmer T, Miederer I, Edison P, Okello A, Van Laere K, Nelissen N, Vandenbulcke M, Garibotto V, et al. (2013) A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. Eur J Nucl Med Mol Imaging 40:104-114.
40. Popp J, Meichsner S, Kolsch H, Lewczuk P, Maier W, Kornhuber J, Jessen F, Lutjohann D (2013) Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's disease. Biochem Pharmacol 86:37-42.
41. Smith GE, Bohac DL, Waring SC, Kokmen E, Tangalos EG, Ivnik RJ, Petersen RC (1998) Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects. Neurology 50:355-362.
42. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CJ, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, et al. (2011) Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:280-292.
43. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90:1977-1981.
44. Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J (2004) Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology 62:1977-1983.
45. Verghese PB, Castellano JM, Holtzman DM (2011) Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 10:241-252.
46. Whitehair DC, Sherzai A, Emond J, Raman R, Aisen PS, Petersen RC, Fleisher AS (2010) Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment. Alzheimers Dement 6:412-419.
47. Woods AG, Sokolowska I, Taurines R, Gerlach M, Dudley E, Thome J, Darie CC (2012) Potential biomarkers in psychiatry: focus on the cholesterol system. J Cell Mol Med 16:1184-1195.
48. Zhou YT, Zhang ZX, Chan P, He XM, Tang MN, Wu CB, Hong Z (2008) Genetic association between low-density lipoprotein receptor-related protein gene polymorphisms and Alzheimer's disease in Chinese Han population. Neurosci Lett 444:109-111.
49. Zhuang JP, Wang G, Cheng Q, Wang LL, Fang R, Liu LH, Xiong R, Zhang Y, Gui YX, Kang WY, Tang HD, Chen SD (2012) Cognitive impairment and the associated risk factors among the elderly in the Shanghai urban area: a pilot study from China. Transl Neurodegener 1:22.